BeyondSpring Inc - חוב לטווח קצר של החברה BYSI

BeyondSpring Inc. (BYSI) net income is shaped by cross-platform management balancing regulatory risks and investment openness. The current level of short-term debt clearly demonstrates financial dynamics, where the 0.00 mark indicates the level of liabilities. Late-stage drug trials are creating negative operating leverage, while the development of immunity protection agents for chemotherapy targets the global market.

Short-term debt measures the total liabilities with a maturity of up to one year, allowing investors to assess liquidity and the risk of working capital deficits. When analyzing short-term accounts payable, it should be noted that the moderate leverage of BeyondSpring Inc. (BYSI) maintains logistics flexibility for oncology drug chemical components, preventing raw material supply chain disruptions through the prompt financing of contracts.